USD 0.0
(0.0%)
Breakdown | 2021 | 2020 | 2019 | 2012 | 2011 | 2010 |
---|---|---|---|---|---|---|
Operating Cash Flow | -106.04 Thousand | -24.13 Thousand | -60.00 | -37.2 Thousand | -21.1 Thousand | -17.73 Thousand |
Net Income | -77.59 Thousand | -7082.00 | -10.56 Thousand | -41.31 Thousand | -21.67 Thousand | -29.48 Thousand |
Depreciation & Amortization | - | - | - | - | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -28.45 Thousand | -17.05 Thousand | 10.5 Thousand | 4113.00 | 575.00 | 11.75 Thousand |
Other non-cash items | - | - | - | -4113.00 | -575.00 | -11.75 Thousand |
Investing Cash Flow | - | - | - | - | - | - |
Investments in PPE | - | - | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | 106.11 Thousand | 23.99 Thousand | 185.00 | 37.2 Thousand | 21.1 Thousand | 17.73 Thousand |
Debt repayment | -73.05 Thousand | -24 Thousand | - | -37.2 Thousand | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | -325.5 Thousand | -33 Thousand | - | - | - | - |
Common Stock Issuance | 360 Thousand | - | 23 Thousand | - | - | - |
Other Financing Activities | -1437.00 | 32.99 Thousand | -22.81 Thousand | 37.2 Thousand | 21.1 Thousand | 17.73 Thousand |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | 4113.00 | 575.00 | 11.75 Thousand |
Inventory | - | - | - | - | - | - |
Other working capital | -28.45 Thousand | -17.05 Thousand | 10.5 Thousand | - | - | - |
Cash at beginning of period | 1.00 | 125.00 | - | - | - | - |
Cash at end of period | 74.00 | 1.00 | 125.00 | - | - | - |
Capital Expenditure | - | - | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | 73.00 | -124.00 | 125.00 | - | - | - |
Free Cash Flow | -106.04 Thousand | -24.13 Thousand | -60.00 | -37.2 Thousand | -21.1 Thousand | -17.73 Thousand |
Breakdown | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | - | - | - | - | -9170.00 | -31.22 Thousand |
Depreciation & Amortization | - | - | - | - | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | - | - | 500.00 | - |
Other non-cash items | - | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | -12.39 Thousand | -130 Thousand |
Investments in PPE | - | - | - | - | - | - |
Acquisitions | - | - | - | - | -12.39 Thousand | -130 Thousand |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | 17.88 Thousand | 164.99 Thousand |
Debt repayment | - | - | - | - | -25.49 Thousand | -54.99 Thousand |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | 110 Thousand |
Other Financing Activities | - | - | - | - | -7605.00 | - |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | - | - | 500.00 | - |
Cash at beginning of period | - | - | - | 1995.00 | 5175.00 | 1408.00 |
Cash at end of period | - | - | - | 1995.00 | 1995.00 | 5175.00 |
Capital Expenditure | - | - | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | - | - | - | -3180.00 | 3767.00 |
Free Cash Flow | - | - | - | - | -8670.00 | -31.22 Thousand |
MAB1
HOFI
NZERF
KPL
VISI
HGH